19 results
Thumbnail

- D1.536 - Immunological basis of coexisting slowly progressive insulin-dependent diabetes mellitus (SPIDDM) and Vogt–Koyanagi–Harada disease (VKH)

Thumbnail

- D1.537 - Immunopharmacogenomics as a Systems Medicine Framework for Precision Therapy in Allergic and Immune Mediated Diseases

Thumbnail

- D1.538 - First Report of the SERPING1 c.52-1G>A Variant in a Chinese HAE Pedigree: Severe Abdominal Phenotype Correlated with Attack-Phase Imaging

Thumbnail

- D1.540 - Automated generation of real-world clinical databases in Allergy: a data-driven research framework

Thumbnail

- D1.541 - Addressing Allergy undergraduate education: Strategic Reforms for Specialist-Led Allergy teaching in Medical Curricula. A EAACI Tailored Education Committee Task Force

Thumbnail

D3.274 - Feasibility of Digestive Enzyme Supplementation for Cow’s Milk Allergy in Exclusively Breastfed Infants

Thumbnail

D3.271 - Development of a multiplex assay to assess the risk of IgE cross-reactivity to new protein sources

Thumbnail

D3.275 - In silico based assessment of intrinsic protein features for ranking clinical relevance of plant-based food allergens

Thumbnail

D3.277 - Tolerance to canned fish in patients allergic to β -parvalbumins

Thumbnail

D3.278 - Tropomyosin-Driven Cross-Reactivity Between Shellfish and House Dust Mites: A Case Report

Thumbnail

D3.279 - SWEET HONEY AND SOUR ALLERGIES: POLLEN-FOOD DEFENSIN CROSS-REACTIVITY - a case series

Thumbnail

D3.281 - A Challenging Case of Paediatric Potato Allergy with Discordant Diagnostic Findings

Thumbnail

D3.282 - A Case of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Food Allergy

Thumbnail

D3.280 - Severe Anaphylaxis Induced by Turkey Egg with Tolerance to Hen’s Egg and Poultry Meat: A First Report

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.447 - Pre-clinical Toxicology and Immunogenicity Evidence as a Precursor of the Successful Phase I/IIA Study with VLP Peanut

Thumbnail

D3.448 - Use of Sebetralstat as Short-term Prophylaxis for Patients with Hereditary Angioedema: Results from the KONFIDENT-S Study